Control of neglected tropical diseases needs a long-term commitment

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Zhang, Yaobi ^a   MacArthur, Chad ^a   Mubila, Likezo ^b   Baker, Shawn ^a  

^a HELEN KELLER INTERNATIONAL   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AZITHROMYCIN; DIETHYLCARBAMAZINE; IVERMECTIN; MEBENDAZOLE; PRAZIQUANTEL;

ARTICLE; ASCARIASIS; ASCARIS LUMBRICOIDES; BEHAVIOR CHANGE; CASE MANAGEMENT; CHLAMYDIA TRACHOMATIS; DISEASE TRANSMISSION; DRUG INDUSTRY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEALTH PROGRAM; HELMINTHIASIS; HOOKWORM INFECTION; HUMAN; INFECTION CONTROL; LONG TERM CARE; LYMPHATIC FILARIASIS; MASS SCREENING; NONHUMAN; ONCHOCERCIASIS; PREVALENCE; PUBLIC-PRIVATE PARTNERSHIP; RISK REDUCTION; SANITATION; SCHISTOSOMIASIS; TRACHOMA; TREATMENT RESPONSE; TRICHURIASIS; TRICHURIS; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASE; DEVELOPING COUNTRY; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; METHODOLOGY; NEGLECTED DISEASE; PROGRAM DEVELOPMENT; REVIEW; TROPICAL MEDICINE;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; ELEPHANTIASIS, FILARIAL; FINANCING, ORGANIZED; HEALTH POLICY; HELMINTHIASIS; HUMANS; NEGLECTED DISEASES; ONCHOCERCIASIS; PROGRAM DEVELOPMENT; SCHISTOSOMIASIS; TRACHOMA; TROPICAL MEDICINE;

EID: 77958560630     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-67     Document Type: Article

References (81)

1. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2005, 2:e336. 10.1371/journal.pmed.0020336, 1253619, 16212468.
2. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 2006, 3:e102. 10.1371/journal.pmed.0030102, 1351920, 16435908.
3. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, Savioli L. Control of neglected tropical diseases. N Engl J Med 2007, 357:1018-1027. 10.1056/NEJMra064142, 17804846.
4. Mathew AA, Turner A, Taylor HR. Strategies to control trachoma. Drugs 2009, 69:953-970. 10.2165/00003495-200969080-00002, 19496626.
5. Wright HR, Turner A, Taylor HR. Trachoma. Lancet 2008, 371:1945-1954. 10.1016/S0140-6736(08)60836-3, 18539226.
6. Stingl P. Onchocerciasis: developments in diagnosis, treatment and control. Int J Dermatol 2009, 48:393-396. 10.1111/j.1365-4632.2009.03843.x, 19335425.
7. Berger IB, Nnadozie J. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists. J Am Optom Assoc 1993, 64:699-702.
8. Ottesen EA, Hooper PJ, Bradley M, Biswas G. The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2008, 2:e317. 10.1371/journal.pntd.0000317, 2556399, 18841205.
9. Hepburn NC. Cutaneous leishmaniasis: an overview. J Postgrad Med 2003, 49:50-54. 10.4103/0022-3859.928, 12865571.
10. Barrett R. Self-mortification and the stigma of leprosy in northern India. Med Anthropol Q 2005, 19:216-230. 10.1525/maq.2005.19.2.216, 15974328.
11. Hartzell JD, Zapor M, Peng S, Straight T. Leprosy: a case series and review. South Med J 2004, 97:1252-1256. 10.1097/01.SMJ.0000146549.63078.39, 15646765.
12. Pszolla N, Sarkar MR, Strecker W, Kern P, Kinzl L, Meyers WM, Portaels F. Buruli ulcer: a systemic disease. Clin Infect Dis 2003, 37:e78-82. 10.1086/377170, 12955667.
13. Fevre EM, Wissmann BV, Welburn SC, Lutumba P. The burden of human african trypanosomiasis. PLoS Negl Trop Dis 2008, 2:e333. 10.1371/journal.pntd.0000333, 2602597, 19104653.
14. Kennedy PG. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann Neurol 2008, 64:116-126. 10.1002/ana.21429, 18756506.
15. Sanchez-Sancho F, Campillo NE, Paez JA. Chagas disease: progress and new perspectives. Curr Med Chem 2010, 17:423-52. 10.2174/092986710790226101, 20015038.
16. Ong A, Sandar M, Chen MI, Sin LY. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis 2007, 11:263-267. 10.1016/j.ijid.2006.02.012, 16899384.
17. Kheir MM, Eltoum IA, Saad AM, Ali MM, Baraka OZ, Homeida MM. Mortality due to Schistosomiasis mansoni: a field study in Sudan. Am J Trop Med Hyg 1999, 60:307-310.
18. Hotez PJ, Molyneux DH. Tropical anemia: one of Africa's great killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goal. PLoS Negl Trop Dis 2008, 2:e270. 10.1371/journal.pntd.0000270, 2474697, 18665256.
19. Brooker S, Hotez PJ, Bundy DA. Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl Trop Dis 2008, 2:e291. 10.1371/journal.pntd.0000291, 2553481, 18820740.
20. Stephenson LS. Helminth parasites, a major factor in malnutrition. World Health Forum 1994, 15:169-172.
21. Stephenson LS, Latham MC, Ottesen EA. Malnutrition and parasitic helminth infections. Parasitology 2000, 121(Suppl):S23-38. 10.1017/S0031182000006491, 11386688.
22. Bates I, McKew S, Sarkinfada F. Anaemia: a useful indicator of neglected disease burden and control. PLoS Med 2007, 4:e231. 10.1371/journal.pmed.0040231, 1945036, 17696641.
23. Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 2005, 21:386-392. 10.1016/j.pt.2005.06.006, 15967725.
24. Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009, 3:e412. 10.1371/journal.pntd.0000412, 2727001, 19707588.
25. Raso G, Luginbuhl A, Adjoua CA, Tian-Bi NT, Silue KD, Matthys B, Vounatsou P, Wang Y, Dumas ME, Holmes E, Singer BH, Tanner M, N'goran EK, Utzinger J. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Cote d'Ivoire. Int J Epidemiol 2004, 33:1092-1102. 10.1093/ije/dyh241, 15256525.
26. McKenzie FE. Polyparasitism. Int J Epidemiol 2005, 34:221-222. author reply 222-223, 10.1093/ije/dyh399, 2504334, 15659470.
27. Conteh L, Engels T, Molyneux DH. Socioeconomic aspects of neglected tropical diseases. Lancet 2010, 375:239-247. 10.1016/S0140-6736(09)61422-7, 20109925.
28. Ehrenberg JP, Ault SK. Neglected diseases of neglected populations: thinking to reshape the determinants of health in Latin America and the Caribbean. BMC Public Health 2005, 5:119. 10.1186/1471-2458-5-119, 1318484, 16283932.
29. Brady MA, Hooper PJ, Ottesen EA. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol 2006, 22:285-291. 10.1016/j.pt.2006.05.007, 16730230.
30. World Health Organization Preventive Chemotherapy in Human Helminthiasis 2006, Geneva, Switzerland: World Health Organization, World Health Organization.
31. African Programme for Onchocerciasis Control Report of the sixth meeting of national task forces, October 2009. Wkly Epidemiol Rec 2010, 85:23-28. African Programme for Onchocerciasis Control.
32. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 2008, 102(Suppl 1):25-29. 10.1179/136485908X337454, 18718151.
33. Hougard JM, Poudiougo P, Zerbo G, Meyer R, Guillet P, Agoua H, Seketeli A, Akpoboua A, Sowah S, Samba EM, et al. Control of onchocerciasis vectors in West Africa: description of the logistics adapted for a large-scale public health program [in French]. Sante 1994, 4:389-398.
34. Amazigo U. The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2008, 102(Suppl 1):19-22. 10.1179/136485908X337436, 18718149.
35. Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konate L, Mounkoro K, Sarr MD, Seck AF, Toé L, Tourée S, Remme JH. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 2009, 3:e497. 10.1371/journal.pntd.0000497, 2710500, 19621091.
36. Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75:491-503. 2487030, 9509621.
37. Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 2006, 61:395-441. 10.1016/S0065-308X(05)61010-X, 16735170.
38. Sun DJ. Global significance of the elimination of lymphatic filariasis in China [in Chinese]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2005, 23(5 Suppl):329-331.
39. World Health Organization Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec 2008, 83:333-341. World Health Organization.
40. Cheun HI, Lee JS, Cho SH, Kong Y, Kim TS. Elimination of lymphatic filariasis in the Republic of Korea: an epidemiological survey of formerly endemic areas, 2002-2006. Trop Med Int Health 2009, 14:445-449. 10.1111/j.1365-3156.2009.02240.x, 19228352.
41. Cheun HI, Kong Y, Cho SH, Lee JS, Chai JY, Lee JK, Kim TS. Successful control of lymphatic filariasis in the Republic of Korea. Korean J Parasitol 2009, 47:323-335. 10.3347/kjp.2009.47.4.323, 2788710, 19967079.
42. World Health Organization Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec 2009, 84:437-444. World Health Organization.
43. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006, 367:992-999. 10.1016/S0140-6736(06)68426-2, 16564361.
44. Fenwick A, Zhang Y. Schistosomiasis. Infectious Diseases 2010, Amsterdam, The Netherlands: Elsevier, Cohen J, Opal SM, Powderly WG, 3, 2927598, 20670408.
45. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006, 6:411-425. 10.1016/S1473-3099(06)70521-7, 16790382.
46. Xianyi C, Liying W, Jiming C, Xiaonong Z, Jiang Z, Jiagang G, Xiaohua W, Engels D, Minggang C. Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992-2001). Bull World Health Organ 2005, 83:43-48. 2623468, 15682248.
47. Wang L, Utzinger J, Zhou XN. Schistosomiasis control: experiences and lessons from China. Lancet 2008, 372:1793-1795. 10.1016/S0140-6736(08)61358-6, 18930529.
48. Katz N. Schistosomiasis control in Brazil. Mem Inst Oswaldo Cruz 1998, 93(Suppl 1):33-35.
49. Webbe G, el Hak S. Progress in the control of schistosomiasis in Egypt 1985-1988. Trans R Soc Trop Med Hyg 1990, 84:394-400. 10.1016/0035-9203(90)90334-B, 2124392.
50. Stothard JR, Gabrielli AF. Schistosomiasis in African infants and preschool children: to treat or not to treat?. Trends Parasitol 2007, 23:83-86. 10.1016/j.pt.2007.01.005, 17241815.
51. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, Zhang Y, Garba A, Stothard JR, Gabrielli AF, Clements AC, Kabatereine NB, Toure S, Dembele R, Nyandindi U, Mwansa J, Koukounari A. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 2009, 136:1719-1730. 10.1017/S0031182009990400, 19631008.
52. Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, Tukahebwa E, Stothard JR, Webster JP, Fenwick A. Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med 2007, 5:27. 10.1186/1741-7015-5-27, 2014753, 17767713.
53. Toure S, Zhang Y, Bosque-Oliva E, Ky C, Ouedraogo A, Koukounari A, Gabrielli AF, Bertrand S, Webster JP, Fenwick A. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull World Health Organ 2008, 86:780-787. A, 10.2471/BLT.07.048694, 2649514, 18949215.
54. Kabatereine NB, Brooker S, Koukounari A, Kazibwe F, Tukahebwa EM, Fleming FM, Zhang Y, Webster JP, Stothard JR, Fenwick A. Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren. Bull World Health Organ 2007, 85:91-99. 10.2471/BLT.06.030353, 2174620,2174620, 17308729.
55. Koukounari A, Gabrielli AF, Toure S, Bosque-Oliva E, Zhang Y, Sellin B, Donnelly CA, Fenwick A, Webster JP. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 2007, 196:659-669. 10.1086/520515, 17674306.
56. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569. 10.1016/S0140-6736(05)66457-4, 15866310.
57. World Health Organization How to Add Deworming to Vitamin A Distribution 2004, Geneva, Switzerland: World Health Organization, World Health Organization.
58. CWW A closer look at soil-transmitted helminth (STH) infections. CWW., http://www.childrenwithoutworms.org/
59. WHO Deworming for health and development. WHO., http://whqlibdoc.who.int/hq/2005/who_cds_cpe_pvc_2005.14.pdf
60. Burton MJ, Mabey DC. The global burden of trachoma: a review. PLoS Negl Trop Dis 2009, 3:e460. 10.1371/journal.pntd.0000460, 2761540, 19859534.
61. West SK. Blinding trachoma: prevention with the safe strategy. Am J Trop Med Hyg 2003, 69(5 Suppl):18-23.
62. Chami Y, Hammou J, Mahjour J. Lessons from the moroccan national trachoma control programme. Community Eye Health 2004, 17:59. 1705736, 17491824.
63. Mariotti SP, Pararajasegaram R, Resnikoff S. Trachoma: looking forward to Global Elimination of Trachoma by 2020 (GET 2020). Am J Trop Med Hyg 2003, 69(5 Suppl):33-35.
64. Kumaresan JA, Mecaskey JW. The global elimination of blinding trachoma: progress and promise. Am J Trop Med Hyg 2003, 69(5 Suppl):24-28.
65. Liang S, Yang C, Zhong B, Qiu D. Re-emerging schistosomiasis in hilly and mountainous areas of Sichuan, China. Bull World Health Organ 2006, 84:139-144. 10.2471/BLT.05.025031, 2626530, 16501732.
66. Merck Merck MECTIZAN Donation Program. Merck., http://www.merck.com/corporate-responsibility/access/access-developing-emerging/mectizan-donation-riverblindness/approach.html
67. GlaxoSmithKline Our commitment on LF. GlaxoSmithKline., http://www.gsk.com/filariasis/commitment.htm
68. Fenwick A, Zhang Y, Stoever K. Control of the neglected tropical diseases in sub-Saharan Africa: the unmet needs. International Health 2009, 1:61-70.
69. Haddad D. The NGDO co-ordination group for onchocerciasis control. Ann Trop Med Parasitol 2008, 102(Suppl 1):35-38. 10.1179/136485908X337472, 18718153.
70. Molyneux DH. Neglected tropical diseases - beyond the tipping point?. Lancet 2010, 375:3-4. 10.1016/S0140-6736(09)61914-0, 20109840.
71. Garba A, Toure S, Dembele R, Bosque-Oliva E, Fenwick A. Implementation of national schistosomiasis control programmes in West Africa. Trends Parasitol 2006, 22:322-326. 10.1016/j.pt.2006.04.007, 16690357.
72. Cantey PT, Rout J, Rao G, Williamson J, Fox LM. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis 2010, 4:e728. 10.1371/journal.pntd.0000728, 2900179, 20628595.
73. Tohon ZB, Mainassara HB, Garba A, Mahamane AE, Bosque-Oliva E, Ibrahim ML, Duchemin JB, Chanteau S, Boisier P. Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerian schoolchildren. PLoS Negl Trop Dis 2008, 2:e241. 10.1371/journal.pntd.0000241, 2386241, 18509472.
74. Knopp S, Mohammed KA, Rollinson D, Stothard JR, Khamis IS, Utzinger J, Marti H. Changing patterns of soil-transmitted helminthiases in Zanzibar in the context of national helminth control programs. Am J Trop Med Hyg 2009, 81:1071-1078. 10.4269/ajtmh.2009.09-0377, 19996439.
75. Stothard JR, French MD, Khamis IS, Basanez MG, Rollinson D. The epidemiology and control of urinary schistosomiasis and soil-transmitted helminthiasis in schoolchildren on Unguja Island, Zanzibar. Trans R Soc Trop Med Hyg 2009, 103:1031-1044. 10.1016/j.trstmh.2009.03.024, 19409588.
76. Gyapong JO, Gyapong M, Yellu N, Anakwah K, Amofah G, Bockarie M, Adjei S. Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities. Lancet 2010, 375:160-165. 10.1016/S0140-6736(09)61249-6, 20109893.
77. McCoy D, Chopra M, Loewenson R, Aitken JM, Ngulube T, Muula A, Ray S, Kureyi T, Ijumba P, Rowson M. Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities. Am J Public Health 2005, 95:18-22. 10.2105/AJPH.2004.040121, 1449845, 15623853.
78. Victora CG, Hanson K, Bryce J, Vaughan JP. Achieving universal coverage with health interventions. Lancet 2004, 364:1541-1548. 10.1016/S0140-6736(04)17279-6, 15500901.
79. Hopkins AD. Challenges for the integration of mass drug administrations against multiple 'neglected tropical diseases'. Ann Trop Med Parasitol 2009, 103(Suppl 1):S23-31. 10.1179/000349809X12502035776559, 19843395.
80. Kabatereine NB, Fleming FM, Nyandindi U, Mwanza JC, Blair L. The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol 2006, 22:332-339. 10.1016/j.pt.2006.05.001, 16713357.
81. Kolaczinski JH, Kabatereine NB, Onapa AW, Ndyomugyenyi R, Kakembo AS, Brooker S. Neglected tropical diseases in Uganda: the prospect and challenge of integrated control. Trends Parasitol 2007, 23:485-493. 10.1016/j.pt.2007.08.007, 2682772,2682772, 17826335.